286 related articles for article (PubMed ID: 27153293)
1. Multimodal quantitative MRI assessment of cortical damage in relapsing-remitting multiple sclerosis.
Gracien RM; Jurcoane A; Wagner M; Reitz SC; Mayer C; Volz S; Hof SM; Fleischer V; Droby A; Steinmetz H; Groppa S; Hattingen E; Deichmann R; Klein JC
J Magn Reson Imaging; 2016 Dec; 44(6):1600-1607. PubMed ID: 27153293
[TBL] [Abstract][Full Text] [Related]
2. Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Al-Radaideh A; Mougin OE; Lim SY; Chou IJ; Constantinescu CS; Gowland P
NMR Biomed; 2015 Nov; 28(11):1374-82. PubMed ID: 26346925
[TBL] [Abstract][Full Text] [Related]
3. Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
Jurcoane A; Wagner M; Schmidt C; Mayer C; Gracien RM; Hirschmann M; Deichmann R; Volz S; Ziemann U; Hattingen E
J Magn Reson Imaging; 2013 Dec; 38(6):1454-61. PubMed ID: 23554005
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal quantitative MRI assessment of cortical damage in multiple sclerosis: A pilot study.
Gracien RM; Reitz SC; Hof SM; Fleischer V; Droby A; Wahl M; Steinmetz H; Groppa S; Deichmann R; Klein JC
J Magn Reson Imaging; 2017 Nov; 46(5):1485-1490. PubMed ID: 28240801
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis.
Rubin M; Pagani E; Preziosa P; Meani A; Storelli L; Margoni M; Filippi M; Rocca MA
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200271. PubMed ID: 38896808
[TBL] [Abstract][Full Text] [Related]
6. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
[TBL] [Abstract][Full Text] [Related]
7. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
Samson RS; Cardoso MJ; Muhlert N; Sethi V; Wheeler-Kingshott CA; Ron M; Ourselin S; Miller DH; Chard DT
Mult Scler; 2014 Sep; 20(10):1322-30. PubMed ID: 24552746
[TBL] [Abstract][Full Text] [Related]
8. Focal cortical thinning in patients with stable relapsing-remitting multiple sclerosis: cross-sectional-based novel estimation of gray matter kinetics.
Orbach L; Menascu S; Hoffmann C; Miron S; Achiron A
Neuroradiology; 2018 Feb; 60(2):179-187. PubMed ID: 29285552
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
Yaldizli Ö; Pardini M; Sethi V; Muhlert N; Liu Z; Tozer DJ; Samson RS; Wheeler-Kingshott CA; Yousry TA; Miller DH; Chard DT
Mult Scler; 2016 Feb; 22(2):150-9. PubMed ID: 26014608
[TBL] [Abstract][Full Text] [Related]
10. Quantitative T
Harper JG; York EN; Meijboom R; Kampaite A; Thrippleton MJ; Kearns PKA; Valdés Hernández MDC; Chandran S; Waldman AD;
Eur Radiol; 2024 Jun; 34(6):3826-3839. PubMed ID: 37943312
[TBL] [Abstract][Full Text] [Related]
11. The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis.
Gracien RM; Jurcoane A; Wagner M; Reitz SC; Mayer C; Volz S; Hof SM; Fleischer V; Droby A; Steinmetz H; Zipp F; Hattingen E; Deichmann R; Klein JC
PLoS One; 2016; 11(8):e0161036. PubMed ID: 27513853
[TBL] [Abstract][Full Text] [Related]
12. Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: A case-controlled magnetization transfer ratio study.
Jakimovski D; Ramanathan M; Weinstock-Guttman B; Bergsland N; Ramasamay DP; Carl E; Dwyer MG; Zivadinov R
Mult Scler; 2020 Mar; 26(3):322-332. PubMed ID: 30755085
[TBL] [Abstract][Full Text] [Related]
13. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
14. Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
Reitz SC; Hof SM; Fleischer V; Brodski A; Gröger A; Gracien RM; Droby A; Steinmetz H; Ziemann U; Zipp F; Deichmann R; Klein JC
Brain Imaging Behav; 2017 Jun; 11(3):744-753. PubMed ID: 27138529
[TBL] [Abstract][Full Text] [Related]
15. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
[TBL] [Abstract][Full Text] [Related]
16. Spatial Correlation of Pathology and Perfusion Changes within the Cortex and White Matter in Multiple Sclerosis.
Mulholland AD; Vitorino R; Hojjat SP; Ma AY; Zhang L; Lee L; Carroll TJ; Cantrell CG; Figley CR; Aviv RI
AJNR Am J Neuroradiol; 2018 Jan; 39(1):91-96. PubMed ID: 29097413
[TBL] [Abstract][Full Text] [Related]
17. Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis.
Crescenzo F; Marastoni D; Zuco C; Pitteri M; Magliozzi R; Monaco S; Calabrese M
Mult Scler Relat Disord; 2019 Jan; 27():305-311. PubMed ID: 30453199
[TBL] [Abstract][Full Text] [Related]
18. Imaging gray matter with concomitant null point imaging from the phase sensitive inversion recovery sequence.
Mougin O; Abdel-Fahim R; Dineen R; Pitiot A; Evangelou N; Gowland P
Magn Reson Med; 2016 Nov; 76(5):1512-1516. PubMed ID: 26599705
[TBL] [Abstract][Full Text] [Related]
19. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA
Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
[TBL] [Abstract][Full Text] [Related]
20. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
Rovaris M; Agosta F; Sormani MP; Inglese M; Martinelli V; Comi G; Filippi M
Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
